40 results
PRE 14A
LRMR
Larimar Therapeutics Inc
12 Apr 24
Preliminary proxy
6:06am
AND COMPOSITION
CRITERIA FOR BOARD MEMBERSHIP
BOARD DIVERSITY
BOARD OVERSIGHT OF COMPANY CULTURE AND ENVIRONMENTAL, SOCIAL AND GOVERNANCE HIGHLIGHTS
DIRECTOR … and who can apply their experience toward meaningful contributions to our business strategy and oversight of our performance, risk management
8-K
EX-1.1
LRMR
Larimar Therapeutics Inc
16 Feb 24
Entry into a Material Definitive Agreement
4:06pm
accounting firm as required by the Securities Act, the Exchange Act, and the rules of the Public Company Accounting Oversight Board (“PCAOB”).
(h
8-K
EX-1.1
h2o4uk
14 Sep 22
Entry into a Material Definitive Agreement
9:01am
8-K
EX-10.1
0cv1f v98
21 May 21
Entry into a Material Definitive Agreement
9:30am
8-K/A
EX-99.2
62ukti
26 Jun 20
Other Events
5:08pm
8-K/A
EX-99.3
4l800c
26 Jun 20
Other Events
5:08pm
8-K
EX-10.1
fngxw at3jj2x
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
DEFM14A
fzag4
29 Apr 20
Proxy related to merger
3:20pm
PRER14A
dbruacs53c85m04kk0n
10 Apr 20
Preliminary revised proxy
4:38pm
PREM14A
acxgqdusr fo
6 Mar 20
Preliminary proxy related to merger
5:32pm